VALANX Biotech, a synthetic biology company headquartered in Austria, has revealed the successful acquisition of €2.3 million in a growth funding round.
Copyright © 2023. Founders Today. All rights reserved
Your go-to source for the latest Startup developments.
Would you like us to send you the latest news from the startup world?